Drug intelligence / Profile preview

N-{2,2-difluoro-2-[(2R)-piperidin-2-yl]ethyl}-2-[2-(1H-1,2,4-triazol-1-yl)benzyl][1,3]oxazolo[4,5-c]pyridin-4-amine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is an experimental small molecule with the chemical formula C22H23F2N7O and a molecular weight of approximately 439.46 g/mol. It contains structural motifs including a difluorinated ethyl group attached to a piperidine ring and an oxazolo[4,5-c]pyridine core substituted with both triazole and benzyl groups. There is no evidence of clinical development or approved therapeutic use for this molecule as of now. Its mechanism of action and biological targets are not described in public databases; it appears to be primarily referenced in chemical structure repositories as an experimental or research compound rather than as an active pharmaceutical ingredient.

Other names
(R)-2-(2-(1H-1,2,4-triazol-1-yl)benzyl)-N-(2,2-difluoro-2-(piperidin-2-yl)ethyl)oxazolo[4,5-c]pyridin-4-amineOxazolo[4,5-c]pyridin-4-amine N-[2,2-difluoro-2-[(2R)-piperidin-2-yl]ethyl]-2-[[2-(1H-1,2,4-triazol-1-yl)phenyl]methyl]PubChem CID: 52874921Ligand ID: 382 (PDB)

Beyond the preview

Go deeper on N-{2,2-difluoro-2-[(2R)-piperidin-2-yl]ethyl}-2-[2-(1H-1,2,4-triazol-1-yl)benzyl][1,3]oxazolo[4,5-c]pyridin-4-amine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-{2,2-difluoro-2-[(2R)-piperidin-2-yl]ethyl}-2-[2-(1H-1,2,4-triazol-1-yl)benzyl][1,3]oxazolo[4,5-c]pyridin-4-amine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call